• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (3)
    • Histopathological insights into mitral valve prolapse-induced fibrosis.
    • Intramyocardial, autologous CD34+ cell therapy for refractory angina.
    • Simple Electroencephalographic Treatment-Emergent Marker Can Predict Repetitive Transcranial Magnetic Stimulation Antidepressant Response-A Feasibility Study.
    • See All 3 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Intramyocardial, autologous CD34+ cell therapy for refractory angina.

Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res. 2011 Aug 05; 109(4):428-36.

View in: PubMed

subject areas
  • Aged
  • Angina Pectoris
  • Antigens, CD34
  • Biomarkers
  • Blood Component Removal
  • Cardiovascular Agents
  • Coronary Circulation
  • Double-Blind Method
  • Endothelial Cells
  • Exercise Test
  • Exercise Tolerance
  • Female
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Least-Squares Analysis
  • Male
  • Microcirculation
  • Middle Aged
  • Myocardial Ischemia
  • Myocardium
  • Neovascularization, Physiologic
  • Prospective Studies
  • Regeneration
  • Regression Analysis
  • Risk Assessment
  • Risk Factors
  • Surveys and Questionnaires
  • Time Factors
  • Tomography, Emission-Computed, Single-Photon
  • Transplantation, Autologous
  • Treatment Outcome
  • United States

authors with profiles
  • Robert Harrington